Consensus DexCom, Inc.

Stocks

DXCM

US2521311074

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe BZX 20:53:55 23/09/2026 BST			5-day change	1st Jan Change
88.04 ^USD	-1.66%		+0.54%	+32.30%

09-17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
09-16	Dexcom Insider Sold Shares Worth $679,769, According to a Recent SEC Filing	MT

Evolution of the Average Target: DexCom, Inc.

Evolution of the Target Price: DexCom, Inc.

Changes in Analyst Recommendations: DexCom, Inc.

9425b604092d1.zCNJ4jmJBOncTOZXfoH4B5BAU30DJJat2A4EKs5nXQ0.pVIgtVD-apGsHogvU_vOftEzaghsQvvvgTxXbLQdCW6jdDHPW_h1nL05gQ~85a44ba852e7a395831194493b876476

Analysts' recommendations: DexCom, Inc.

09-17	Truist Securities Adjusts DexCom Price Target to $102 From $93, Maintains Buy Rating	MT
08-13	Citigroup Adjusts Price Target on DexCom to $105 From $88, Maintains Buy Rating	MT
08-04	Argus Adjusts Price Target on DexCom to $96 From $86, Maintains Buy Rating	MT
08-03	UBS Adjusts Price Target on DexCom to $102 From $96, Maintains Buy Rating	MT
08-03	Rothschild & Co Redburn Adjusts Price Target on DexCom to $100 From $90, Maintains Buy Rating	MT
07-31	DexCom Glucose Monitors' National Coverage Could Support H2 Upside, RBC Capital Markets Says	MT
07-31	Leerink Partners Adjusts Price Target on DexCom to $94 From $80, Maintains Outperform Rating	MT
07-31	RBC Raises Price Target on DexCom to $90 From $85, Keeps Outperform Rating	MT
07-31	Canaccord Genuity Adjusts Price Target on DexCom to $90 From $82, Maintains Buy Rating	MT
07-31	Evercore ISI Adjusts Price Target on DexCom to $100 From $90, Maintains Outperform Rating	MT
07-31	Mizuho Adjusts Price Target on DexCom to $95 From $90, Maintains Outperform Rating	MT
07-31	Benchmark Adjusts Price Target on DexCom to $82 From $77, Maintains Buy Rating	MT
07-31	Bernstein Adjusts Price Target on DexCom to $90 From $77, Maintains Outperform Rating	MT
07-31	Deutsche Bank Adjusts DexCom Price Target to $92 From $86, Maintains Buy Rating	MT
07-31	Truist Raises Price Target on DexCom to $93 From $87, Keeps Buy Rating	MT
07-31	Baird Adjusts Price Target on DexCom to $105 From $80, Maintains Outperform Rating	MT
07-31	JPMorgan Adjusts Price Target on DexCom to $82 From $65, Maintains Neutral Rating	MT
07-31	Piper Sandler Adjusts Price Target on DexCom to $95 From $88, Maintains Overweight Rating	MT
07-31	Wells Fargo Adjusts Price Target on DexCom to $90 From $85, Maintains Overweight Rating	MT
07-31	Stifel Adjusts Price Target on DexCom to $95 From $90, Maintains Buy Rating	MT
07-31	Citigroup Adjusts Price Target on DexCom to $88 From $84, Maintains Buy Rating	MT
07-31	Jefferies Adjusts Price Target on DexCom to $115 From $112, Maintains Buy Rating	MT
07-31	BTIG Adjusts Price Target on DexCom to $90 From $80, Maintains Buy Rating	MT
07-31	Raymond James Adjusts Price Target on DexCom to $94 From $91, Maintains Strong Buy Rating	MT
07-31	Analyst recommendations: Apple, Baxter International, Dexcom, Flex, Humana, Stellantis…

More recommendations

Other Medical Equipment, Supplies & Distribution

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Consensus	Analysts' recommendations evolution (4 months)	Financial estimates divergence	Analysts' Target price divergence	Objective/dr gap
	DEXCOM, INC.					+5.53%
	ABBOTT LABORATORIES					+15.98%
	MEDTRONIC PLC					+15.49%
	CENCORA, INC.					+17.45%
	BECTON, DICKINSON AND COMPANY					+6.92%
	HOYA CORPORATION					+33.6%
	MEDLINE INC.					+29.54%
	WEST PHARMACEUTICAL SERVICES, INC.					+9.83%
	SARTORIUS STEDIM BIOTECH					+14.1%
	TERUMO CORPORATION					+38.96%
	Average					+18.74%
	Weighted average by Cap.					+17.28%